Page 79 - Read Online

targets for cancer therapy. Biochem Pharmacol 2010;80:690-701. DNA damage induced by curcumin in human hepatoma G2 cells.
51. Aziz MTA, Khaled HM, Hindawi AE, Roshdy NK, Rashed LA, Toxicol Sci 2006;91:476-83.
Sabry D , Hassouna AA, Taha F, Ali WI. Effect of mesenchymal stem 67. Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J, Liu K, Duan W.
cells and novel curcumin derivative on Notch1 signaling in hepatoma Epithelial cell adhesion molecule aptamer functionalized PLGA-
cell line. Biomed Res Int 2013;2013:e129629. lecithin-curcumin-PEG nanoparticles for targeted drug delivery to
52. Rao TP, Kuhl M. An updated overview on Wnt signaling pathways: a human colorectal adenocarcinoma cells. Int J Nanomed 2014;9:1083-
prelude for more. Circ Res 2010;106:1798-806. 96.
53. Xu MX, Zhao L, Deng C, Yang L, Wang Y, Guo T, Li L, Lin J, Zhang 68. Mendonca LM, da Silva MC, Teixeira CC, de Freitas LA, Bianchi
L. Curcumin suppresses proliferation and induces apoptosis of ML, Antunes LM. Curcumin reduces cisplatin-induced neurotoxicity
human hepatocellular carcinoma cells via the wnt signaling pathway. in NGF-differentiated PC12 cells. Neurotoxicol 2013;34:205-11.
Int J Oncol 2013;43:1951-9. 69. Julie SJ. Anti-inflammatory properties of curcumin, a major
54. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, constituent of curcuma longa: a review of preclinical and clinical
Patumraj S. Anti-cancer and anti-antigenic effects of curcumin and research. Altern Med Rev 2009;1:141-53.
tetrahydrocurcumin on implanted hepatocellular carcinoma in nude 70. Aggarwal BB, Harikumar KB. Potential therapeutic effects of
mice. World J Gastroenterol 2008;14:2003-9. curcumin, the anti-inflammatory agent, against neurodegenerative,
55. Aza-Blanc P, Kornberg TB. Ci: a complex transducer of the hedgehog cardiovascular, pulmonary, metabolic, autoimmune and neoplastic
signal. Trends Genet 1999;15:458-62. diseases. Int J Biochem Cell Biol 2009;41:40-59.
56. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y, 71. Nagpal M, Sood S. Role of curcumin in systemic and oral health: an
Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, overview. J Nat Sci Biol Med 2013;4:3-7.
Diehl AM. Dysregulation of the Hedgehog pathway in human 72. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung
hepatocarcinogenesis. Carcinogenesis 2006;27:748-57. B, Sethi G, Aggarwal BB. Role of prooxidants and antioxidants
57. Mujoo K, Nikonoff LE, Sharin VG, Bryan NS, Kots AY, Murad F. in the anti-inflammatory and apoptotic effects of curcumin
Curcumin induces differentiation of embryonic stem cells through (diferuloylmethane). Free Radic Biol Med 2007;43:568-80.
possible modulation of nitric oxide-cyclic GMP pathway. Protein 73. Toydemir T, Kanter M, Erboga M, Oquz S, Erenoglu C.
Cell 2012;3:535-44. Antioxidative, antiapoptotic, and proliferative effect of curcumin
58. Fox SB, Gasparini G, Harris AL. Angiogenesis: Pathological, on liver regeneration after partial hepatectomy in rats. Toxicol Ind
prognostic and growth factor pathways and their link to trial design Health 2015;31:162-72.
and anticancer drugs. Lancet Oncol 2001;2:278-89. 74. Cui S, Qu X, Xie Y, Zhou L, Nakata M, Makuuchi M, Tang W.
59. Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung Curcumin inhibits telomerase activity in human cancer cell lines. Int
JJ. Cyclooxigenase-2 pathway correlates with vascular endothelial J Mol Med 2006;18:227-31.
growth factor expression and tumor angiogenesis in hepatitis-B 75. Zhao X, Chen Q, Liu W, Li Y, Tang H, Liu X, Yang X. Codelivery
virus-associated hepatocellular carcinoma. Int J Oncol 2004;24:853- of doxorubicin and curcumin with lipid nanoparticles results
60. in improved efficacy of chemotherapy in liver cancer. Int J
60. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative Nanomedicine 2014;10:257-70.
stress, inflammation and cancer: how are they linked? Free Radic 76. Ganta S, Devalapally H, Amiji M. Curcumin enhances oral
Biol Med 2010;49:1603-16. bioavailability and anti-tumor therapeutic efficacy of paclitaxel
61. Cao J, Liu Y, Jia L, Zhou HM, Kong Y, Ynag G, Jiang LP, Li QJ, upon administration in nanoemulsion formulation. J Pharm Sci
Zhong LF. Curcumin induces apoptosis through mitochondrial 2010;99:4630-41.
hyperpolarization and mtDNA damage in human hepatoma G2 cells. 77. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M,
Free Radic Boil Med 2007;43:968-75. D’Alessandro N. Antitumor effects of curcumin, alone or in
62. Aggarwal BB, Bhatt ID, Ichikawa H, Ahn KS, Sethi G, Sandur SK, combination with cisplatin or doxorubicin, on human hepatic
Sundaram C, Seeram N, Shishodia S. Curcumin-biological and cancer cells. Analysis of their possible relationship to changes in
medicinal properties. New York, USA: CRC press; 2007. NF-kB activation levels and in IAP gene expression. Cancer Lett
63. Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K, Pang JCS, Ng HK, 2005;224:53-5.
Chen ZP. Clinical significance of vasculogenic mimicry in human 78. Zhu R, Wu X, Xiao Y, Gao B, Xie Q, Liu H, Wang S. Synergetic
gliomas. J Neurooncol 2011;105:173-9. effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer
64. Liang Y, Huang M, Li J, Sun X, Jiang X, Li L, Ke Y. Curcumin inhibits cell line. Cancer Biother Radiopharm 2013;28:579-87.
vasculogenic mimicry through the downregulation of erythropoietin- 79. Qian H, Yang Y, Wang X. Curcumin enhanced adriamycin-induced
producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase human liver-derived hepatoma G2 cell death through activation of
and matrix metalloproteinase-2. Oncol Lett 2014;8:1849-55. mitochondria-mediated apoptosis and autophagy. Eur J Pharm Sci
65. Farazuddin M, Dua B, Zia Q, Khan AA, Joshi B, Owais M. 2011;43:125-31.
Chemotherapeutic potential of curcumin bearing microcells against 80. Nasr M, Selima E, Hamed O, Kazem A. Targeting different antigenic
hepatocellular carcinoma in model animals. Int J Nanomedicine pathways with combination of curcumin, leflunomide and perindopril
2014;9:1139-52. inhibits diethylnitrosamine-induced hepatocellular carcinoma in
66. Cao J, Jia L, Zhou HM, Liu Y, Zhong LF. Mitochondrial and nuclear mice. Eur J Pharmacol 2014;723:267-75.

70 Hepatoma Research | Volume 2 | March 9, 2016